Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended versus routine warfarin for prevention of recurrent venous thromboembolism after first unprovoked VTE
2010-022119-20Phase 4Unknown
- Sponsor
- University of Birmingham
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in venous thromboembolism (VTE) (2 arms), sponsored by University of Birmingham. Primary endpoint: Recurrent thrombotic events. Status: unknown.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2010-022119-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022119-20.